New Advances in the Prediction of NMIBC Recurrence by Genetic Biomarkers
-
Published:2023
Issue:06
Volume:13
Page:10534-10541
-
ISSN:2161-8712
-
Container-title:Advances in Clinical Medicine
-
language:
-
Short-container-title:ACM
Publisher
Hans Publishers
Subject
General Engineering
Reference49 articles.
1. European Association of Urology Guidelines on Non–muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ)
2. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
3. van Rhijn, B.W.G., Hentschel, A.E., Bründl, J., Compérat, E.M., Hernán-dez, V., Čapoun, O., et al. (2021) Prognostic Value of the WHO1973 and WHO2004/2016 Classification Systems for Grade in Primary Ta/T1 Non-Muscle-Invasive Bladder Cancer: A Multicenter European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel Study. European Urology Oncology, 4, 182-191.
4. DeGeorge, K.C., Holt, H.R. and Hodges, S.C. (2017) Bladder Cancer: Diagnosis and Treatment. Ameri-can Family Physician, 96, 507-514.
5. Epidemiology of Bladder Cancer